You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

BACTROBAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Bactroban patents expire, and when can generic versions of Bactroban launch?

Bactroban is a drug marketed by Glaxosmithkline and is included in three NDAs.

The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bactroban

A generic version of BACTROBAN was approved as mupirocin by PADAGIS ISRAEL on November 7th, 2003.

  Try a Trial

Summary for BACTROBAN
US Patents:0
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 87
Clinical Trials: 19
Patent Applications: 4,627
Drug Prices: Drug price information for BACTROBAN
What excipients (inactive ingredients) are in BACTROBAN?BACTROBAN excipients list
DailyMed Link:BACTROBAN at DailyMed
Drug patent expirations by year for BACTROBAN
Drug Prices for BACTROBAN

See drug prices for BACTROBAN

Drug Sales Revenue Trends for BACTROBAN

See drug sales revenues for BACTROBAN

Recent Clinical Trials for BACTROBAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lindenhof AGPhase 4
Lindenhofgruppe AGPhase 4
St. Louis Children's HospitalPhase 2

See all BACTROBAN clinical trials

US Patents and Regulatory Information for BACTROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline BACTROBAN mupirocin OINTMENT;TOPICAL 050591-001 Dec 31, 1987 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BACTROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for BACTROBAN

See the table below for patents covering BACTROBAN around the world.

Country Patent Number Title Estimated Expiration
Japan S6117583 CRYSTALLINE CALCIUM PSEUDOMONATE, MANUFACTURE AND MEDICINAL COMPOSITION ⤷  Try a Trial
African Intellectual Property Organization (OAPI) 10361 Novel composition ⤷  Try a Trial
Israel 75536 CRYSTALLINE CALCIUM PSEUDOMONATE,ITS PREPARATION AND PHARMACEUTICAL AND VETERINARY COMPOSITIONS COMPRISING IT ⤷  Try a Trial
Norway 313446 ⤷  Try a Trial
Bulgaria 62912 ⤷  Try a Trial
Jordan 1420 ⤷  Try a Trial
United Kingdom 8415579 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.